Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | ATM | Q13315 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | ANPEP | P15144 | 1/20 | 0.43 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 4/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23163258 | 1.00 | MEN1 (0.64) | MEN1KMT2AMAPTATMHSD17B10 | |
| SCHEMBL16115683 | 1.00 | MEN1 (0.64) | MEN1KMT2AMAPTATMHSD17B10 | |
| SCHEMBL19947656 | 1.00 | MEN1 (0.64) | MEN1KMT2AMAPTATMHSD17B10 | |
| SCHEMBL14511330 | 1.00 | MEN1 (0.64) | MEN1KMT2AMAPTATMHSD17B10 | |
| SCHEMBL915393 | 1.00 | MEN1 (0.64) | MEN1KMT2AMAPTATMHSD17B10 | |
| SCHEMBL29025599 | 0.97 | KMT2A (0.59) | MEN1KMT2AMAPTATMHSD17B10 | |
| SCHEMBL65035 | 0.97 | — | — | |
| SCHEMBL19617353 | 0.97 | — | — | |
| SCHEMBL25299343 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL8578344 | 0.95 | KMT2A (0.56) | MEN1KMT2AMAPTATMHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250179233-A1 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2025-06-05 | — | — | US | claimed |
| US-20250144087-A1 | USE OF VE607 FOR THE TREATMENT OF SARS-COV-2 INFECTIONS AND RELATED DISEASES | FINZI ANDRES (CA) | 2025-05-08 | — | — | US | claimed |
| EP-4486808-A2 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2025-01-08 | — | — | EP | claimed |
| CN-119137172-A | Process and catalyst for hydrogen-mediated anionic copolymerization of conjugated dienes and liquid copolymers thereof | 雅宝公司 | 2024-12-13 | — | — | CN | claimed |
| CN-117751004-A | Carbon dioxide capture system | 氢涞新能源科技(美国)公司 | 2024-03-22 | — | — | CN | claimed |
| US-20240034825-A1 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC POLYMERIZATION OF CONJUGATED DIENES AND LIQUID POLYMERS THEREOF | ALBEMARLE CORPORATION | 2024-02-01 | — | — | US | claimed |
| WO-2023168218-A2 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC COPOLYMERIZATION OF CONJUGATED DIENES AND LIQUID COPOLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2023-09-07 | — | — | WO | claimed |
| EP-4208485-A1 | PROCESS AND CATALYSTS FOR HYDROGEN MEDIATED ANIONIC POLYMERIZATION OF CONJUGATED DIENES AND LIQUID POLYMERS THEREOF | ALBEMARLE CORPORATION (US) | 2023-07-12 | — | — | EP | claimed |
| CN-116368159-A | Process and catalyst for hydrogen-mediated anionic polymerization of conjugated dienes and liquid polymers thereof | 雅宝公司 | 2023-06-30 | — | — | CN | claimed |
| US-20230151136-A1 | CATALYST COMPOSITION FOR POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-18 | — | — | US | claimed |
| CN-102639686-A | Cleaning fluid composition and a cleaning method for a panel using the same | DONGWOO FINE CHEM CO LTD | 2012-08-15 | — | — | CN | claimed |
| CN-102482208-A | Ionic Liquid Containing Allyl Sulfonate Anion | WAKO PURE CHEM IND LTD | 2012-05-30 | — | — | CN | claimed |
| WO-2008100621-A2 | TETRAHYDRO-PYRAZOLO-PYRIDINE THIOETHER MODULATORS OF CATHEPSIN S | SUNESIS PHARMACEUTICALS, INC. (US) | 2008-08-21 | — | — | WO | claimed |
| EP-0670053-A1 | SOLID ANTIFOGGANT AGENT AND SOLID SINGLE PART HIGH CONTRAST RAPID ACCESS DEVELOPER | SUN CHEMICAL CORPORATION (US) | 1995-09-06 | — | — | EP | claimed |
| WO-1994011783-A1 | SOLID ANTIFOGGANT AGENT AND SOLID SINGLE PART HIGH CONTRAST RAPID ACCESS DEVELOPER | SUN CHEMICAL CORPORATION (US) | 1994-05-26 | — | — | WO | claimed |
| US-5272045-A | Water soluble antifoggant for powder developer solutions | SUN CHEMICAL CORPORATION (US) | 1993-12-21 | — | — | US | claimed |
| CN-86101899-A | The manufacturing process of 2-chloro-1- pyridine-propane | — | 1987-01-24 | — | — | CN | claimed |
| EP-0058434-B1 | N-2-HYDROXYPROPYL PIPERIDINES AND PROCESS FOR PREPARING THE SAME | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1985-06-19 | — | — | EP | claimed |
| US-4405737-A | OLEFIN STABILIZERS | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1983-09-20 | — | — | US | claimed |
| EP-0058434-A1 | N-2-hydroxypropyl piperidines and process for preparing the same | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1982-08-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250144087-A1 | USE OF VE607 FOR THE TREATMENT OF SARS-COV-2 INFECTIONS AND RELATED DISEASES | ACE2, ACE, TMPRSS2 | MEN1 4042/4885KMT2A 2716/4885MAPT 1147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.